d'Amore, F A, Radford, J, Jerkeman, M, Relander, T, Tilly, H, Osterborg, A, Morschhauser, F, Gramatzki, M, Dreyling, M, Bang, B, Baadsgaard, O & Hagberg, H 2007, ' Zanolimumab (HuMax-CD4), a fully human monoclonal antibody: Efficacy and safety in patients with relapsed or treatment-refractory non-cutaneous CD4+ T-cell lymphoma ', Blood, pp. 3409 .